Inactive Instrument

Brighter AB (publ)

BRIG

SE0004019545

Advanced Medical Equipment & Technology

Brighter's Interim CEO Erik Lissner Takes Permanent Role as the Company CEO

June 30, 2022 at 03:06 am EDT

Brighter AB (publ) announced that the company has agreed on a contract with Erik Lissner regarding his permanent role as CEO at Brighter. The agreed contract takes effect June 30, 2022.

Latest news about Brighter AB (publ)

Brighter Files for Bankruptcy After Court Orders End to Corporate Restructuring	22-11-23	MT
Brighter Postpones Publication of Third Quarter Report	22-11-23	CI
Nasdaq Stockholm Fines Brighter For Violating Listing Rules On Insider Information	22-11-23	MT
Brighter Dips Over 55% as Court Orders End to Corporate Restructuring	22-11-21	MT
Brighter Surges 181% As It Enters Corporate Restructuring	22-11-02	MT
Brighter Shares Plunge 63% on Corporate Restructuring Plan	22-11-01	MT
Brighter AB Applies for Corporate Restructuring in Bid for Longer-Term Financing	22-11-01	CI
Brighter Falls 17% as Stockholm Court OKs Nectarine Health's Bankruptcy Application	22-10-17	MT
Brighter Unit Receives Regulatory Approval for Corporate Restructuring	22-09-30	MT
Swedish Regulator Investigates Brighter's Former Chairman, CEO	22-09-26	MT
Brighter Unit Applies for Corporate Restructuring	22-09-23	MT
Brighter Subsidiary Faces Repayment Demand From Swedish Tax Agency	22-09-15	MT
Brighter Boosts Loan Financing Deal With Formue Nord Markedsneutral	22-09-13	MT
Brighter AB Expands Loan Financing with Formue Nord Markedsneutral of SEK 10.0 Million	22-09-13	CI
Brighter CFO Steps Down; Interim Finance Chief Named	22-09-06	MT
Brighter AB Announces Executive Changes	22-09-06	CI
Brighter Plans $5 Million Rights Issue to Fund Commercialization of Actiste Device; Shares Sink 25%	22-08-25	MT
Brighter AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25	CI
Brighter Receives UAE Regulatory Approval For Actiste Device	22-08-02	MT
Brighter AB (Publ.) Announces its Actiste® Receives Telecommunication Type Approval in the United Arab Emirates	22-08-02	CI
Brighter Receives Regulatory Approval In UAE For Pilot Research on Diabetes Treatment	22-07-21	MT
Brighter AB Receives Final Approvals for Pilot Research with Insulin-Treated Diabetes Patients in the UAE	22-07-21	CI
Brighter Confirms Interim CEO To Permanent Role	22-06-30	MT
Brighter Confirms Interim CEO	22-06-30	MT
Brighter's Interim CEO Erik Lissner Takes Permanent Role as the Company CEO	22-06-30	CI

Brighter AB (publ) is a Sweden-based technology company engaged in the healthcare sector. The Company offers solutions related to diabetes care, welfare technology and digital healthcare services. Brighter AB (publ) is a Parent Company, that operates through group of subsidiaries. The group's main purpose is to improve health and wellbeing amongst the global population through development of technical and digital medical devices with a primary area of application in the treatment of diabetes. The Company reports the following operating segments: Brighter, Camanio and Nectarine Health.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+4.36%	32.47B
PRO MEDICUS LIMITED	+14.14%	7.45B
SECTRA AB	+22.93%	3.89B
EVOLENT HEALTH, INC.	-16.29%	3.15B
OMNICELL, INC.	-25.96%	1.28B
LUNIT INC.	-36.14%	1.09B
B-SOFT CO.,LTD.	-35.42%	902M
SIMULATIONS PLUS, INC.	-0.13%	893M
VERADIGM INC.	-24.12%	857M

Medical Software & Technology Services

Brighter AB (publ)

Equities

BRIG

SE0004019545

Advanced Medical Equipment & Technology

Brighter's Interim CEO Erik Lissner Takes Permanent Role as the Company CEO

Latest news about Brighter AB (publ)

Chart Brighter AB (publ)

Company Profile

Sector Medical Software & Technology Services